Highline Wealth Partners
IONS icon

Highline Wealth Partners’s Ionis Pharmaceuticals IONS Stock Holding History

Highline Wealth Partners’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.7K Hold
38
– – ﹤0.01% 1273
2026
Q2 		$3.01K Hold
38
– – ﹤0.01% 1036
2026
Q1 		$2.85K Hold
38
– – ﹤0.01% 927
2025
Q4 		$3.01K Hold
38
– – ﹤0.01% 732
2025
Q3 		$2.49K Hold
38
– – ﹤0.01% 814
2025
Q2 		$1.5K Hold
38
– – ﹤0.01% 673
2025
Q1 		$1.15K Buy
+38
New +$1.24K ﹤0.01% 722

Other funds holding IONS

Pinnacle Associates
Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
Motley Fool Asset Management
Motley Fool Asset Management Alexandria, Virginia $2.64B AUM 26.58% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
Exchange Traded Concepts
Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Highline Wealth Partners's IONS Position: Q3 2026 in Review

Highline Wealth Partners held its Ionis Pharmaceuticals (IONS) position steady in Q3 2026 at 38 shares worth $1.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1273.

Highline Wealth Partners first reported a position in IONS in Q1 2025 and has held it in 7 quarters since. The position peaked at $3.01K in Q2 2026. 97 funds tracked by Wall St. Rank hold IONS as of Q3 2026.

  • Highline Wealth Partners held 38 shares of Ionis Pharmaceuticals worth $1.7K as of Q3 2026.
  • Highline Wealth Partners left its Ionis Pharmaceuticals share count unchanged in Q3 2026.
  • Ionis Pharmaceuticals made up ﹤0.01% of Highline Wealth Partners's portfolio in Q3 2026, its #1273 holding.
  • Highline Wealth Partners first reported a position in Ionis Pharmaceuticals in Q1 2025 and has held it in 7 quarters since.
  • Highline Wealth Partners's Ionis Pharmaceuticals position peaked at $3.01K in Q2 2026.
  • 97 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.

Based on Highline Wealth Partners's 13F filing for Q3 2026, filed 19 Oct 2026.